Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $186 | $164 | $153 | $170 |
| - Cash | $0 | $29 | $25 | $19 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | $185 | $136 | $129 | $153 |
| Revenue | $0 | $22 | $23 | $23 |
| % Growth | -99.3% | -2.1% | -2.3% | – |
| Gross Profit | $0 | $11 | $11 | $12 |
| % Margin | 49.1% | 49.9% | 48.3% | 50.5% |
| EBITDA | $0 | $3 | $3 | $4 |
| % Margin | 20.5% | 14.7% | 11.9% | 15.2% |
| Net Income | $0 | $5 | $3 | $4 |
| % Margin | 13.8% | 20.4% | 13.8% | 15.5% |
| EPS Diluted | 0.53 | 107.87 | 72.91 | 82.99 |
| % Growth | -99.5% | 47.9% | -12.1% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |